Haemonetics Corp/ US4050241003 /
| 2024-05-10 10:10:00 PM | Chg. +3.26 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 95.86USD | +3.52% | 445,067 Turnover: 30.37 mill. |
91.34Bid Size: 100 | 153.24Ask Size: 100 | 4.87 bill.USD | - | 42.23 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 2.27 USD | 167.06% |
| EPS Diluted: | 2.24 USD | 166.67% |
| Revenues per Share: | 23.12 USD | 19.38% |
| Book Value per Share: | 16.18 USD | 10.74% |
| Cash Flow per Share: | 5.40 USD | 60.82% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 1,168.66 USD | 17.67% |
| Net Income: | 115.40 USD | 166.05% |
| Operating Cash Flow: | 273.06 USD | - |
| Cash and Cash Equivalents: | 284.47 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 42.23 | 36.45 |
| P/S Ratio: | 4.15 | 3.58 |
| P/BV ratio: | 5.92 | 5.11 |
| P/CF Ratio: | 17.74 | 15.32 |
| PEG: | 0.25 | 0.22 |
| Earnings Yield: | 2.37% | 2.74% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 4.87 bill. USD | 4.18 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 50.79 mill. | |
Profitability
| Gross Profit Margin: | 52.63% |
| EBIT Margin: | 13.35% |
| Net Profit Margin: | 9.87% |
| Return on Equity: | 14.11% |
| Return on Assets: | 5.96% |
Financial Strength
| Liquidity I / Cash Ratio: | 112.97% |
| Liquidity II / Quick Ratio: | 184.11% |
| Liquidity III / Current Ratio: | 305.67% |
| Debt / Equity Ratio: | 136.53% |
| Dynam. Debt / Equity Ratio: | 409.01% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-04-01 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
